SeaStar Medical Holding Corporation (ICU)
(Delayed Data from NSDQ)
$0.37 USD
+0.01 (1.42%)
Updated May 31, 2024 04:00 PM ET
After-Market: $0.37 0.00 (-0.38%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for SeaStar Medical Holding Corporation falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 0 | 0 | 0 | 0 | NA |
Cost Of Goods | 0 | 0 | 0 | 0 | NA |
Gross Profit | 0 | 0 | 0 | 0 | NA |
Selling & Adminstrative & Depr. & Amort Expenses | 14 | 12 | 1 | 0 | 0 |
Income After Depreciation & Amortization | -14 | -12 | -1 | 0 | 0 |
Non-Operating Income | -11 | -11 | 1 | 0 | NA |
Interest Expense | 1 | 1 | 0 | 0 | NA |
Pretax Income | -26 | -23 | 0 | 0 | NA |
Income Taxes | 0 | 0 | 0 | 0 | NA |
Minority Interest | 0 | 0 | 0 | 0 | NA |
Investment Gains/Losses | 0 | 0 | 0 | 0 | NA |
Other Income/Charges | 0 | 0 | 0 | 0 | NA |
Income From Cont. Operations | -26 | -23 | 0 | 0 | NA |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | NA |
Net Income (GAAP) | -26 | -23 | 0 | 0 | NA |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -14 | -11 | -1 | 0 | 0 |
Depreciation & Amortization (Cash Flow) | 0 | 0 | 0 | 0 | NA |
Income After Depreciation & Amortization | -14 | -12 | -1 | 0 | 0 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 21.67 | 8.21 | NA | NA | NA |
Diluted EPS Before Non-Recurring Items | -0.98 | -2.80 | NA | NA | NA |
Diluted Net EPS (GAAP) | -1.21 | -2.80 | 0.02 | 0.00 | NA |
Fiscal Year end for SeaStar Medical Holding Corporation falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Cost Of Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A, R&D, and Dept/Amort Expenses | 3.95 | 2.95 | 2.94 | 3.75 | 4.58 |
Income After SG&A, R&D, and Dept/Amort Expenses | -3.95 | -2.95 | -2.94 | -3.75 | -4.58 |
Non-Operating Income | -8.60 | -7.13 | -4.27 | 0.31 | -0.25 |
Interest Expense | 0.14 | 0.20 | 0.22 | 0.23 | 0.43 |
Pretax Income | -12.70 | -9.88 | -7.43 | -3.66 | -5.26 |
Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -12.70 | -9.88 | -7.43 | -3.66 | -5.26 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -12.70 | -9.88 | -7.43 | -3.66 | -5.26 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | 67.11 | 21.67 | 20.05 | 14.93 | 13.03 |
Diluted EPS Before Non-Recurring Items | -0.19 | -0.19 | -0.12 | -0.25 | -0.40 |
Diluted Net EPS (GAAP) | -0.19 | -0.19 | -0.37 | -0.25 | -0.40 |